{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:28:56Z","timestamp":1788809336374,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1124\/jpet.119.262972","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T23:55:12Z","timestamp":1577404512000},"page":"308-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature"],"prefix":"10.1016","volume":"372","author":[{"given":"A. David","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.262972_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2133\/dmpk.20.268","article-title":"The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180","volume":"20","author":"Aiba","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.119.262972_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.115.066845","article-title":"Prediction of drug-drug interactions arising from CYP3A induction using a physiologically based dynamic model","volume":"44","author":"Almond","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/psp4.12457","article-title":"Expanded physiologically-based pharmacokinetic model of rifampicin for predicting interactions with drugs and an endogenous biomarker via complex mechanisms including organic anion transporting polypeptide 1B induction","volume":"8","author":"Asaumi","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib4","doi-asserted-by":"crossref","first-page":"e00222","DOI":"10.1002\/prp2.222","article-title":"UGT concentrations in human rectal tissue after multidose, oral curcumin","volume":"4","author":"Asher","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.119.262972_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-5-4","article-title":"Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa","volume":"5","author":"Bergheim","year":"2005","journal-title":"BMC Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib6","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1124\/dmd.113.051698","article-title":"Atorvastatin treatment induces uptake and efflux transporters in human liver","volume":"41","author":"Bj\u00f6rkhem-Bergman","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib7","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1021\/acs.molpharmaceut.9b00458","article-title":"Transcriptional and post-transcriptional regulation of duodenal P-glycoprotein and MRP2 in healthy human subjects after chronic treatment with rifampin and carbamazepine","volume":"16","author":"Brueck","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.262972_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11095-018-2458-6","article-title":"Characterization of intestinal and hepatic CYP3A-mediated metabolism of midazolam in children using a physiological population pharmacokinetic modelling approach","volume":"35","author":"Brussee","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.262972_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00196857","article-title":"Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa","volume":"47","author":"Buchthal","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib10","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","article-title":"The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis","volume":"292","author":"Bush","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.262972_bib11","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41598-018-22170-7","article-title":"Characterization of exosomal SLC22A5 (OCTN2) carnitine transporter","volume":"8","author":"Console","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.262972_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ibd.20030","article-title":"Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1)","volume":"13","author":"Englund","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.119.262972_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.xphs.2018.09.024","article-title":"Dysregulation of mucosal membrane transporters and drug-metabolizing enzymes in ulcerative colitis","volume":"108","author":"Erdmann","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.262972_bib14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.105.005611","article-title":"Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age","volume":"33","author":"Fakhoury","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(99)70554-8","article-title":"Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers","volume":"117","author":"Fontana","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.119.262972_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters","volume":"157","author":"Fromm","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.119.262972_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40495-017-0087-0","article-title":"Remote sensing between liver and intestine: importance of microbial metabolites","volume":"3","author":"Fu","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"10.1124\/jpet.119.262972_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1989.tb03516.x","article-title":"The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction","volume":"28","author":"Ged","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clpt.2003.10.004","article-title":"CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects","volume":"75","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2125.2004.02265.x","article-title":"Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes","volume":"59","author":"Glaeser","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-9236(98)90146-1","article-title":"The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin","volume":"64","author":"Gorski","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(94)90237-2","article-title":"Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily","volume":"48","author":"Gorski","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib24","doi-asserted-by":"crossref","first-page":"32299","DOI":"10.1038\/srep32299","article-title":"Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines","volume":"6","author":"Gotanda","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.262972_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"Greiner","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.119.262972_bib26","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/jps.23613","article-title":"A mechanistic physiologically based pharmacokinetic-enzyme turnover model involving both intestine and liver to predict CYP3A induction-mediated drug-drug interactions","volume":"102","author":"Guo","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.262972_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FPC.0b013e3282f974b7","article-title":"Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol","volume":"18","author":"Haenisch","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.119.262972_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/psp4.12343","article-title":"PBPK models for CYP3A4 and P-gp DDI prediction: a modeling network of rifampicin, itraconazole, clarithromycin, midazolam, alfentanil, and digoxin","volume":"7","author":"Hanke","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/bjp.2008.69","article-title":"Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells","volume":"154","author":"Haslam","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0009-9236(96)90194-0","article-title":"Determination of cytochrome P450 3A4\/5 activity in vivo with dextromethorphan N-demethylation","volume":"60","author":"Jones","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib31","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","article-title":"Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity","volume":"22","author":"Joy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.119.262972_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/dmd.112.050161","article-title":"A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women","volume":"41","author":"Ke","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.taap.2003.11.015","article-title":"Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers","volume":"199","author":"Kim","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib34","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/AAC.02278-15","article-title":"HIV-1 alters intestinal expression of drug transporters and metabolic enzymes: implications for antiretroviral drug disposition","volume":"60","author":"Kis","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.119.262972_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/dmd.119.087940","article-title":"A comparative analysis of cytochrome P450 activities in paired liver and small intestinal samples from patients with obesity","volume":"48","author":"Krogstad","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FTD.0000000000000510","article-title":"Determination of tacrolimus concentration and protein expression of P-glycoprotein in single human renal core biopsies","volume":"40","author":"Krogstad","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.119.262972_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-9236(96)90022-3","article-title":"Decreased intestinal CYP3A in celiac disease: reversal after successful gluten-free diet: a potential source of interindividual variability in first-pass drug metabolism","volume":"59","author":"Lang","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib38","first-page":"307","article-title":"Laparoscopic wedge biopsy of the liver","volume":"178","author":"Lefor","year":"1994","journal-title":"J Am Coll Surg"},{"key":"10.1124\/jpet.119.262972_bib39","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1124\/dmd.118.082875","article-title":"Cryopreserved human intestinal mucosal epithelium: a novel in vitro experimental system for the evaluation of enteric drug metabolism, cytochrome P450 induction, and enterotoxicity","volume":"46","author":"Li","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0090-9556(25)08440-5","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/C6IB00243A","article-title":"Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS)","volume":"9","author":"Maass","year":"2017","journal-title":"Integr Biol"},{"key":"10.1124\/jpet.119.262972_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000478018","article-title":"Liquid biopsy: current status and future perspectives","volume":"40","author":"Mader","year":"2017","journal-title":"Oncol Res Treat"},{"key":"10.1124\/jpet.119.262972_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.119.262972_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clpt.2003.12.003","article-title":"Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate","volume":"75","author":"McConnachie","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/dmd.106.013342","article-title":"Regional distribution of solute carrier mRNA expression along the human intestinal tract","volume":"35","author":"Meier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib46","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.262972_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/17425255.2018.1473376","article-title":"Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication","volume":"14","author":"Momper","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.119.262972_bib48","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/dmd.114.056929","article-title":"Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters","volume":"42","author":"Mooij","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mcp.2002.124519","article-title":"Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans","volume":"72","author":"Mouly","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clpt.2005.08.014","article-title":"Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5","volume":"78","author":"Mouly","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib51","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1124\/dmd.107.020073","volume":"36","author":"Nakai","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib52","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/FPC.0b013e3280143dfc","article-title":"Effects of rifampicin on global gene expression in human small intestine","volume":"17","author":"Oscarson","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.119.262972_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clpt.2006.08.013","article-title":"Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine","volume":"80","author":"Oscarson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/dmdi-2013-0042","article-title":"Characterization of ABC transporters in human skin","volume":"29","author":"Osman-Ponchet","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/jpet.119.262972_bib55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/clpt.2011.255","article-title":"Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers","volume":"91","author":"Oswald","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17474124.2018.1412828","article-title":"Non-endoscopic biopsy techniques: a review","volume":"12","author":"Otuya","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.119.262972_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1381\/096089206775565159","article-title":"A comparison of wedge and needle hepatic biopsy in open bariatric surgery","volume":"16","author":"Padoin","year":"2006","journal-title":"Obes Surg"},{"key":"10.1124\/jpet.119.262972_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/dmd.116.072249","article-title":"Transcriptional regulation of CYP2D6 expression","volume":"45","author":"Pan","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2125.1986.tb05239.x","article-title":"The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies","volume":"22","author":"Pelkonen","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib60","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2362.1989.tb00273.x","article-title":"Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake","volume":"19","author":"Perrot","year":"1989","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.119.262972_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2125.2005.02343.x","article-title":"Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein","volume":"59","author":"Pinto","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clpt.2004.10.002","article-title":"Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4\/5 activity and expression","volume":"77","author":"Pinto","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00228-012-1339-x","article-title":"Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin","volume":"69","author":"Quinney","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/dmd.109.028746","article-title":"Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin","volume":"38","author":"Quinney","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3565(24)29202-8","article-title":"Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays","volume":"299","author":"Rae","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.262972_bib66","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/cpt.1328","article-title":"From endogenous compounds as biomarkers to plasma-derived nanovesicles as liquid biopsy; has the golden age of translational pharmacokinetics-absorption, distribution, metabolism, excretion-drug-drug interaction science finally arrived?","volume":"105","author":"Rodrigues","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcp.13793","article-title":"Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure","volume":"85","author":"Rowland","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcp.2016.11.007","article-title":"In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation","volume":"123","author":"Sager","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib69","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/dmd.115.065656","article-title":"Defining human pathways of drug metabolism in vivo through the development of a multiple humanized mouse model","volume":"43","author":"Scheer","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1099-081X(199704)18:3<227::AID-BDD18>3.0.CO;2-L","article-title":"Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3\/4, with a possible role of 2E1","volume":"18","author":"Schmider","year":"1997","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.119.262972_bib71","first-page":"839","article-title":"Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms","volume":"10","author":"Smith","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/jpet.119.262972_bib72","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1289\/ehp.8861","article-title":"Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers","volume":"114","author":"Thum","year":"2006","journal-title":"Environ Health Perspect"},{"key":"10.1124\/jpet.119.262972_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/clpt.2012.261","article-title":"Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects","volume":"93","author":"Ulvestad","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4067\/S0716-97602008000100010","article-title":"Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women","volume":"41","author":"Varela","year":"2008","journal-title":"Biol Res"},{"key":"10.1124\/jpet.119.262972_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens","volume":"75","author":"von Richter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701000","article-title":"Multiorgan microphysiological systems for drug development: strategies, advances, and challenges","volume":"7","author":"Wang","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/jpet.119.262972_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00498254.2019.1648911","article-title":"Cytochrome P450: genotype to phenotype","volume":"50","author":"Waring","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.119.262972_bib78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/dmd.117.078626","article-title":"Direct quantification of cytochromes P450 and drug transporters-a rapid, targeted mass spectrometry-based immunoassay panel for tissues and cell culture lysates","volume":"46","author":"Wei\u00df","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jphs.08209FP","article-title":"Induction of multiple drug transporters by efavirenz","volume":"109","author":"Weiss","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.119.262972_bib80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mcp.2000.109797","article-title":"Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug\/drug interaction","volume":"68","author":"Westphal","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.119.262972_bib81","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1021\/acs.molpharmaceut.9b00459","article-title":"Crohn\u2019s disease is associated with decreased CYP3A4 and P-glycoprotein protein expression","volume":"16","author":"Wilson","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.262972_bib82","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib83","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/mol.110.070607","article-title":"Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis","volume":"79","author":"Wu","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib84","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/psp4.12458","article-title":"Physiologically-based pharmacokinetic modeling approach to predict rifampin-mediated intestinal P-glycoprotein induction","volume":"8","author":"Yamazaki","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.119.262972_bib85","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1124\/dmd.109.026658","article-title":"Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite","volume":"37","author":"Zhang","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.262972_bib86","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.262972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:59:27Z","timestamp":1739973567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524269251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0022356524269251"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.262972","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.262972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}